Teen Clinic, cardiovascular kidney metabolic clinic launched at RGGGH
The Rajiv Gandhi Government General Hospital (RGGGH) has established a weekly 'Teen Clinic' for the well-being of adolescents aged 10 to 19 years. The clinic established at a cost of Rs. 14 lakh will function from 8 a.m. to 12 noon on Saturdays.
Along with the Teen Clinic, Health Minister Ma. Subramanian and Hindu Religious and Charitable Endowments Minister P.K. Sekar Babu inaugurated the Centre of Excellence for Diabetology of which a Cardiovascular Kidney Metabolic (CKM) Clinic has been set up, and a temporal bone dissection skill lab set up at a cost of Rs. 2.40 crore at RGGGH on Monday.
The Teen Clinic will offer a multi-disciplinary approach encompassing general medicine, paediatrics, obstetrics and gynaecology, psychiatry, nutrition and dermatology and sexually transmitted infections, a press release said.
Located on the fifth floor of Tower 3, the clinic will provide comprehensive services aimed at addressing the physical, emotional and social needs of adolescents. It aims at enhancing adolescent health awareness including on healthy lifestyles, dietary guidance for obesity and avoiding junk food, and educating them on the hazards of substance abuse including alcohol, smoking and drugs, with psychological approaches for de-addiction, personality disorders, anxiety and depression. It also aims to promote early intervention on adolescent female health, focussing on obesity, irregular menstrual cycles, polycystic ovarian syndrome and sexually transmitted diseases.
At the Centre of Excellence for Diabetology, new laboratory equipment has been procured. Nerve conduction studies to detect neuropathy, sarcopenia assessment for muscle strength, foot assessment, pulsed electromagnetic field therapy for treating painful diabetic neuropathy and full-fledged ophthalmic assessment for early diagnosis of retinopathy are available. In addition, an adult Type 1 diabetes clinic has been set up.
The CKM clinic is meant for patients with diabetes who have developed cardiovascular and renal problems. Three specialists - diabetologist, cardiologist and nephrologist - will be available at the clinic to provide comprehensive care under a single roof. Patients can undergo all investigations and receive drug prescriptions at the clinic, doctors said.
Through the temporal bone dissection skill lab, training will be imparted to ENT doctors across the State, the Minister said.
Health Secretary P. Senthilkumar, National Health Mission, Tamil Nadu Mission Director Arun Thamburaj, Director of Medical Education and Research J. Sangumani, dean of RGGGH K. Shantharam, director and head of department, Institute of Diabetology P. Dharmarajan and director of ENT Suresh Kumar were present.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
&w=3840&q=100)
Business Standard
2 hours ago
- Business Standard
ICICI commits ₹550 cr for Tata Memorial's cancer care centre in Vizag
ICICI Bank and Tata Memorial Centre launch advanced cancer block treat 3,000 patients annually Chennai ICICI Bank will collaborate with Tata Memorial Centre (TMC) to construct an eight-storied building at the Homi Bhabha Cancer Hospital and Research Centre (HBCHRC) in Visakhapatnam to 'serve' 3,000 patients annually, said the lender on Thursday. The bank has committed more than Rs 550 crore for the building that will spread over 3.9 lakh square feet and have the latest in medical technology. ICICI Foundation Block for Child and Blood Cancer will serve 3,000 patients annually at HBCHRC, which has a capacity of 6,200 patients. Designed as one of the largest specialised cancer facilities in India, the new building will house over 215 beds. It is expected to be completed by 2027, subject to necessary approvals. ICICI Foundation for Inclusive Growth, the CSR arm of ICICI Bank, will oversee its implementation. The foundation stone was unveiled by Pradeep Kumar Sinha, chairman of ICICI Bank. Sandeep Batra, executive director of ICICI Bank, and Sudeep Gupta, director of Tata Memorial Centre in Mumbai, attended the event. 'We are honoured to partner with TMC in a mission towards cancer care, that aligns with our philosophy of strengthening critical health care infrastructure in the country. This project reflects our commitment to enabling accessible and high-quality medical care for individuals in need,' said Sinha., Batra said: 'Two years ago, we announced our partnership with TMC by committing Rs 1,200 crore to set up three new blocks at its centres in Visakhapatnam, Navi Mumbai, and New Chandigarh. Recognising TMC's latest requirements, we are pleased to enhance our commitment to ₹1,800 crore.' Umesh Mahantshetty, director of HBCHRC, said: 'We are grateful to ICICI Foundation for their generous donation, which will significantly contribute to the advancement of cancer treatment and research. The partnership with ICICI Foundation is a testament to the collective efforts of our institutions in providing top-notch care and improving cancer outcomes for patients across the country.' 'At HBCHRC Visakhapatnam currently, we have been registering approximately 200 new paediatric cancer and 350-400 haematolymphoid cancer patients every year in the past three years. With the new block added, we will be able to augment the existing services substantially including expansion of bone marrow transplant programme and also initiate immunotherapy,' said Girish Chinnaswamy, professor and head, paediatric oncology, Tata Memorial Hospital, Mumbai. ICICI Bank's commitment of Rs 550 crore for the Visakhapatnam hospital is part of the expanded contribution of ₹1,800 crore.
India Today
3 hours ago
- India Today
97% of Tamil Nadu's elderly have Covid-19 antibodies: What is seropositivity?
A recent serosurvey conducted in Tamil Nadu has revealed that nearly all elderly participants, around 97%, showed seropositivity for means that most of them had protective antibodies against the SARS-CoV-2 virus, which indicates either they were previously exposed to the virus or received is the fifth phase of the Covid-19 serosurvey conducted by the Directorate of Public Health and Preventive Medicine (DPH) and the State Public Health Laboratory (SPHL).advertisement The survey was carried out in April 2024 after a three-year gap, the last such study was conducted in December samples were collected from 3,643 elderly individuals across six districts: Chennai, Tiruvallur, Tiruvannamalai, Tiruchi, Dharmapuri, and is a serosurvey?Serosurveys are used to detect the presence of antibodies in the blood. Most of elderly surveyed in Tamil Nadu had protective antibodies against the SARS-CoV-2 virus. () These antibodies, particularly Immunoglobulin G (IgG), develop after a person is infected with a virus or receives a antibodies are detected through blood tests, the individual is said to be "seropositive."advertisementThis helps scientists and health authorities understand how widely a disease has spread in a community, even among people who did not show symptoms or were never of 1,214 samples that were initially tested in this phase, 97% had IgG antibodies to SARS-CoV-2."In this situation, a non-virulent strain (of SARS-CoV-2) may not cause much impact, but it is important for persons with co-morbidities, pregnant women, immune-compromised persons, and the elderly to take precautions while visiting public places," Tamil Nadu Health Minister Ma. Subramanian told reporters on Wednesday, pointing to the recent surge in new Omicron variants in is seropositivity?According to the National Cancer Institute, seropositivity generally indicates that the immune system has responded to a virus, such as SARS-CoV-2, by creating antibodies. When antibodies are detected through blood tests, the individual is said to be It does not, however, tell us how strong the immunity is or how long it will last. For that, further tests are required to assess the exact nature and strength of the immune global studies show that the effectiveness of vaccines in creating antibodies varies. A 2023 analysis found that after the third dose of Covid-19 vaccines, the rate of seropositivity ranged around 67%, and for specific high-risk groups like solid organ transplant recipients, seroconversion rates improved after booster this context, Tamil Nadu's 97% seropositivity among the elderly stands out as a reassuring InMust Watch
Time of India
4 hours ago
- Time of India
3.45 lakh health cards issued under central schemes: Delhi minister
New Delhi: Delhi Health Minister Pankaj Kumar Singh on Wednesday said over 3.45 lakh health cards have been issued under the Pradhan Mantri Jan Arogya Yojana and the Ayushman Vay Vandana Yojana till date. Of these, 1,66,841 cards have been distributed exclusively under the Vay Vandana Yojana (VVY) -- an initiative aimed at ensuring dignified and secure aging for Delhi's senior citizens, an official statement said. As per data, 1,24,215 cards were issued by self-registrations, 11,284 by BIS operators, and 42,176 through Common Service Centres (CSCs), it said. "The prompt issuance of over 3.45 lakh cards is a testament to the Delhi government's efficient implementation and the people's trust in our healthcare initiatives. We are committed to upholding the dignity and well-being of every senior citizen in the capital," Singh said. As part of the government's expanded healthcare infrastructure, 85 hospitals have been empanelled under the schemes -- 60 private and 25 government-run facilities, allowing beneficiaries to access quality care across both sectors. These cards offer up to Rs 10 lakh in cashless hospitalisation benefits , not just within Delhi but also across empanelled hospitals nationwide. The construction of 1,139 Ayushman Aarogya Mandirs across Delhi is in full swing. The plan is to equip each of Delhi's 70 assembly constituencies with Aarogya Mandirs, bringing healthcare closer to the people. "This very month, over 30 new Ayushman Aarogya Mandirs will be dedicated to the people of Delhi," he added. Every Delhi resident above 70 years, possessing an Aadhaar card, is eligible for registration under Ayushman Vay Vandana Yojana.
